Biocon Limited has informed the Exchange regarding a press release dated July 07, 2025, titled "Biocon Biologics Receives MHRA UK Approval for Vevzuo® and Evfraxy®, Denosumab Biosimilars".
Biocon Limited has informed the Exchange regarding a press release dated July 07, 2025, titled "Biocon Biologics Receives MHRA UK Approval for Vevzuo® and Evfraxy®, Denosumab Biosimilars".